Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G GOSSELIN

Showing results (131-140 of 153) with videos related to

Pageof 16
Sort By:
Nucleosides & Nucleotides|August 5, 1999
Intracellular metabolism of beta-L-ddAMP-bis(tbutylSATE), a potent inhibitor of hepatitis B virus replicationA Faraj, L Placidi, C Perigaud, et al.
Antiviral Research|April 20, 2000
Synthesis and antiviral evaluation of some beta-L-2', 3'-dideoxy-5-chloropyrimidine nucleosides and pronucleotidesC Pierra, J L Imbach, E De Clercq, et al.
Antimicrobial Agents and Chemotherapy|April 2, 1999
Pharmacokinetics of beta-L-2',3'-dideoxy-5-fluorocytidine in rhesus monkeysL T Martin, E Cretton-Scott, R F Schinazi, et al.
The Canadian Journal of Cardiology|February 15, 2001
Impact of residual plaque burden after balloon angioplasty in the MultiVitamins and Probucol (MVP) trialJ C Tardif, G Côté, J Lespérance, et al.
Molecular Pharmacology|August 1, 1988
Effect of the N-glycosidic bond conformation and modifications in the pentose moiety on the binding of nucleoside ligands to uridine phosphorylaseM H el Kouni, F N Naguib, S H Chu, et al.
American Heart Journal|August 1, 1994
Tolerability of enalapril initiation by patients with left ventricular dysfunction: results of the medication challenge phase of the Studies of Left Ventricular DysfunctionJ B Kostis, B J Shelton, S Yusuf, et al.
Circulation|January 13, 1999
Effects of probucol on vascular remodeling after coronary angioplasty. Multivitamins and Protocol Study GroupG Côté, J C Tardif, J Lespérance, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1994
Inhibition of human immunodeficiency virus type 1 reverse transcriptase by the 5'-triphosphate beta enantiomers of cytidine analogsA Faraj, L A Agrofoglio, J K Wakefield, et al.
Journal of Medicinal Chemistry|May 10, 1996
Decomposition pathways and in vitro HIV inhibitory effects of isoddA pronucleotides: toward a rational approach for intracellular delivery of nucleoside 5'-monophosphatesG Valette, A Pompon, J L Girardet, et al.
Nucleosides, Nucleotides & Nucleic Acids|April 25, 2000
In vitro and in vivo metabolism and pharmacokinetics of bis [(t-butyl)-S-acyl-2-thioethyl]-beta-L-2',3'-dideoxy-5-fluorocytidine monophosphateL T Martin, E Cretton-Scott, L Placidi, et al.
Pageof 16

Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
Nucleosides & Nucleotides|August 5, 1999
Intracellular metabolism of beta-L-ddAMP-bis(tbutylSATE), a potent inhibitor of hepatitis B virus replicationA Faraj, L Placidi, C Perigaud, et al.
Antiviral Research|April 20, 2000
Synthesis and antiviral evaluation of some beta-L-2', 3'-dideoxy-5-chloropyrimidine nucleosides and pronucleotidesC Pierra, J L Imbach, E De Clercq, et al.
Antimicrobial Agents and Chemotherapy|April 2, 1999
Pharmacokinetics of beta-L-2',3'-dideoxy-5-fluorocytidine in rhesus monkeysL T Martin, E Cretton-Scott, R F Schinazi, et al.
The Canadian Journal of Cardiology|February 15, 2001
Impact of residual plaque burden after balloon angioplasty in the MultiVitamins and Probucol (MVP) trialJ C Tardif, G Côté, J Lespérance, et al.
Molecular Pharmacology|August 1, 1988
Effect of the N-glycosidic bond conformation and modifications in the pentose moiety on the binding of nucleoside ligands to uridine phosphorylaseM H el Kouni, F N Naguib, S H Chu, et al.
American Heart Journal|August 1, 1994
Tolerability of enalapril initiation by patients with left ventricular dysfunction: results of the medication challenge phase of the Studies of Left Ventricular DysfunctionJ B Kostis, B J Shelton, S Yusuf, et al.
Circulation|January 13, 1999
Effects of probucol on vascular remodeling after coronary angioplasty. Multivitamins and Protocol Study GroupG Côté, J C Tardif, J Lespérance, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1994
Inhibition of human immunodeficiency virus type 1 reverse transcriptase by the 5'-triphosphate beta enantiomers of cytidine analogsA Faraj, L A Agrofoglio, J K Wakefield, et al.
Journal of Medicinal Chemistry|May 10, 1996
Decomposition pathways and in vitro HIV inhibitory effects of isoddA pronucleotides: toward a rational approach for intracellular delivery of nucleoside 5'-monophosphatesG Valette, A Pompon, J L Girardet, et al.
Nucleosides, Nucleotides & Nucleic Acids|April 25, 2000
In vitro and in vivo metabolism and pharmacokinetics of bis [(t-butyl)-S-acyl-2-thioethyl]-beta-L-2',3'-dideoxy-5-fluorocytidine monophosphateL T Martin, E Cretton-Scott, L Placidi, et al.
Pageof 16